Outcomes of laboratory‐confirmed SARS‐CoV‐2 infection in the Omicron‐driven fourth wave compared with previous waves in the Western Cape Province, South …
…, D Pienaar, M Mendelson, J Naude… - Tropical Medicine & …, 2022 - Wiley Online Library
OBJECTIVES The objective was to compare COVID‐19 outcomes in the Omicron‐driven fourth
wave with prior waves in the Western Cape, assess the contribution of undiagnosed prior …
wave with prior waves in the Western Cape, assess the contribution of undiagnosed prior …
[HTML][HTML] Risk factors for COVID-19-related in-hospital mortality in a high HIV and tuberculosis prevalence setting in South Africa: a cohort study
…, JL Bam, MA Davies, HW Prozesky, J Naude… - The Lancet …, 2021 - thelancet.com
Background The interaction between COVID-19, non-communicable diseases, and chronic
infectious diseases such as HIV and tuberculosis is unclear, particularly in low-income and …
infectious diseases such as HIV and tuberculosis is unclear, particularly in low-income and …
Vertebral metastases: assessment with apparent diffusion coefficient
AM Herneth, MO Philipp, J Naude, M Funovics… - Radiology, 2002 - pubs.rsna.org
The authors evaluated the apparent diffusion coefficient (ADC) in the assessment of
vertebral metastases and acute vertebral compression fractures in 22 patients with known or …
vertebral metastases and acute vertebral compression fractures in 22 patients with known or …
[HTML][HTML] Outcomes of laboratory-confirmed SARS-CoV-2 infection during resurgence driven by Omicron lineages BA. 4 and BA. 5 compared with previous waves in the …
…, A Mnguni, M Moodley, K Murie, J Naude… - International Journal of …, 2023 - Elsevier
Objectives We aimed to compare the clinical severity of Omicron BA.4/BA.5 infection with BA.1
and earlier variant infections among laboratory-confirmed SARS-CoV-2 cases in the …
and earlier variant infections among laboratory-confirmed SARS-CoV-2 cases in the …
[HTML][HTML] Convalescent plasma in the treatment of moderate to severe COVID-19 pneumonia: a randomized controlled trial (PROTECT-Patient Trial)
…, A Swarts, C Mmenu, T Crede, G Kritzinger, J Naude… - Scientific reports, 2022 - nature.com
There is a need for effective therapy for COVID-19 pneumonia. Convalescent plasma has
antiviral activity and early observational studies suggested benefit in reducing COVID-19 …
antiviral activity and early observational studies suggested benefit in reducing COVID-19 …
A phase 2A trial of the safety and tolerability of increased dose rifampicin and adjunctive linezolid, with or without aspirin, for human immunodeficiency virus …
…, P Denti, RPJ Lai, T Crede, J Naude… - Clinical Infectious …, 2023 - academic.oup.com
Background Drug regimens that include intensified antibiotics alongside effective anti-inflammatory
therapies may improve outcomes in tuberculous meningitis (TBM). Safety data on …
therapies may improve outcomes in tuberculous meningitis (TBM). Safety data on …
Plasma pharmacokinetics of high-dose oral versus intravenous rifampicin in patients with tuberculous meningitis: a randomized controlled trial
…, R Goliath, A Jackson, T Crede, J Naude… - Antimicrobial agents …, 2021 - Am Soc Microbiol
Higher doses of intravenous rifampicin may improve outcomes in tuberculous meningitis but
are impractical in high-burden settings. We hypothesized that plasma rifampicin exposures …
are impractical in high-burden settings. We hypothesized that plasma rifampicin exposures …
Continuous hyperfractionated accelerated radiotherapy with/without mitomycin C in head and neck cancers
W Dobrowsky, J Naudé - Radiotherapy and Oncology, 2000 - Elsevier
Backgroundand purpose: Radiation therapy is often the primary treatment for advanced
cases of head and neck cancers not considered suitable for radical surgery. In these cases …
cases of head and neck cancers not considered suitable for radical surgery. In these cases …
COVID-19 in-hospital mortality in South Africa: The intersection of communicable and non-communicable chronic diseases in a high HIV prevalence setting
Background: The interaction between COVID-19, non-communicable diseases, and chronic
infectious diseases such as HIV and tuberculosis (TB) are unclear, particularly in low-and …
infectious diseases such as HIV and tuberculosis (TB) are unclear, particularly in low-and …
[HTML][HTML] Cost-effectiveness of single, high-dose, liposomal amphotericin regimen for HIV-associated cryptococcal meningitis in five countries in sub-Saharan Africa: an …
…, S Moosa, T Morar, M Mpalali, J Naude… - The Lancet Global …, 2022 - thelancet.com
Background HIV-associated cryptococcal meningitis is a leading cause of AIDS-related
mortality. The AMBITION-cm trial showed that a regimen based on a single high dose of …
mortality. The AMBITION-cm trial showed that a regimen based on a single high dose of …
